Marc Ballas is an Oncology physician affiliated with GlaxoSmithKline. OpenAlex indexes 183 publications with 1,359 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
160 E 34th St
Rm 820
New York, NY 100164744
Telephone
212-731-6645Registry record last updated 25 Jul 2011.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer
2025 - INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
Cancer Immunology Immunotherapy
2024 - Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Cancer Research Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”